Gene Salkind

Dr. Gene Z.
Salkind, MD, is an Independent Director at Coeptis Therapeutics Holdings, Inc., an Independent Director at Upexi, Inc., a Chairman at Mobiquity Technologies, Inc., an Independent Director at Avenir Wellness Solutions, Inc., a Head-Neurosurgery at Holy Redeemer Health System, a President at Bruno & Salkind Mds and a Professor at Lewis Katz School of Medicine.
He is on the Board of Directors at Coeptis Therapeutics Holdings, Inc., Upexi, Inc., CURE Pharmaceutical Corp., Avenir Wellness Solutions, Inc., Grove Holdings, Inc., Calico Capital Management LLC and Temple University School of Medicine.
Dr. Salkind was previously employed as a Head-Neurosurgery by Albert Einstein Medical Center, a Head-Neurosurgery by Jeanes Hospital, a Professor by Allegheny Health, Education & Research Foundation, and a Professor by University of Pennsylvania.
He also served on the board at DermTech Operations, Inc. and DermTech, Inc. He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from Lewis Katz School of Medicine.